OPTIONAL LICENSES TO NEW NDI TECHNOLOGY Sample Clauses

OPTIONAL LICENSES TO NEW NDI TECHNOLOGY. In the event NDI acquires ownership of New NDI Technology, or files any patent application reflecting New NDI Technology, that it believes is useful in the Epic Field of Use, NDI shall promptly send Epic written notice identifying such New NDI Technology. Epic shall have the right of first negotiation for six months after the receipt of such notice, to negotiate a royalty bearing, exclusive, irrevocable, worldwide license to such New NDI Technology in the Epic Field of Use, which license will bear royalties on Net Sales, but will not include any upfront, milestone or minimum royalty payments. Either party may exercise such right of first negotiation by written notice. In such case, NDI and Epic shall negotiate in good faith for a period of no less than 30 days a reasonable royalty rate for such license. Such royalty rate shall not exceed 5%. The obligations of this Section will remain in effect only for so long as NDI holds at least 30% of the Outstanding Percentage Interests of Epic, as such term is defined in the LLC Agreement. For avoidance of doubt, (a) unless and until Epic exercises its right of first negotiation by written notice, NDI will have no obligation to negotiate with Epic for such license; (b) nothing in this Section will be construed to restrict NDI's right to negotiate for such a license with any Third Party, including during the 30 day period referenced above; and (c) all licenses to be negotiated hereunder are subject to the terms of Section 2.4. However, NDI shall not, for a period of six months after the commencement of such 30-day period, grant a license to New NDI Technology to any Third Party on terms more favorable than the best terms offered by Epic during the 30-day negotiation period. Any dispute regarding what constitutes a reasonable royalty may be submitted to fast-track arbitration as described in Section 4.6. Upon determination of such royalty rate, the applicable Technology will be subject to the licensing terms that are applicable to NDI Background Technology in Article 2 of this Agreement. Epic and NDI acknowledge that any third party restrictions related to New Technology will be identified and made a condition of the license as part of such negotiation process.
Sample 1
AutoNDA by SimpleDocs

Related to OPTIONAL LICENSES TO NEW NDI TECHNOLOGY

  • Additional Licenses For a period of five (5) years following the Distribution Date, in the event any member of the Honeywell Group, in Honeywell’s reasonable judgment, requires a license under any SpinCo IP in order to initiate and pursue any technical projects not covered by the licenses granted in Section 4.01(a), the Parties shall negotiate in good faith to license such SpinCo IP to the applicable member of the Honeywell Group on commercially reasonable terms. Notwithstanding anything to the contrary, if the Parties cannot reach agreement with respect to the terms of a license to SpinCo IP pursuant to the immediately preceding sentence, the applicable member of the Honeywell Group shall be permitted to challenge the validity or enforceability of such SpinCo IP (it being understood that such challenge is the sole remedy available to Honeywell in the event SpinCo does not grant such license, without regard to whether SpinCo has negotiated in good faith).

  • Commercial License Subject to the terms and conditions of this Agreement, CytomX hereby grants to ImmunoGen and its Affiliates an exclusive (even as to CytomX), non-transferable (except as expressly permitted in this Agreement), royalty-bearing license, including the right to grant sublicenses as described in Section 3.1.2 hereof, under the Licensed Intellectual Property, to Develop, make, have made, use, sell, offer for sale, import and otherwise Commercialize Licensed Products in the Field in the Territory. ImmunoGen and its Affiliates shall have the right to engage one or more Affiliates or Third Parties (the latter being referred to herein as “Permitted Third Party Service Providers”) as subcontractors to perform designated functions in connection with its activities under this Agreement (including transferring Licensed Know-How and CytomX Proprietary Materials as may be necessary for such Permitted Third Party Service Providers to perform such designated functions); provided that (a) ImmunoGen shall [***] and (b) ImmunoGen shall [***].

  • Initial License Fee In partial consideration for the exclusive license granted pursuant to Section 2.1 hereof, Licensee shall pay to Scripps a non-refundable license fee upon execution of this Agreement in the amount of 70,000 shares of Licensee common stock as specified in Exhibit D. The license fee described in this Section is consideration for the grant and continuation of the license hereunder, and Scripps shall have no obligation to return any portion of such license fee, notwithstanding any failure by Licensee to develop any Licensed Product or market any Licensed Product commercially, and notwithstanding the volume of sales of any such Licensed Product.

  • Governmental Licenses Obtain and maintain all licenses, permits, certifications and approvals of all applicable Governmental Authorities as are required for the conduct of its business as currently conducted and as contemplated by the Loan Documents, except where the failure to do so could not reasonably be expected to have a Material Adverse Effect.

  • Other Licenses Nothing contained in this Agreement shall be construed as conferring by implication, estoppel or otherwise upon either Party any license or other right except the licenses and rights expressly granted under this Agreement.

  • Permits, Licenses, Etc Each of the Borrower and its Subsidiaries possesses all permits, licenses, patents, patent rights or licenses, trademarks, trademark rights, trade names rights, and copyrights which are material to the conduct of its business. Each of the Borrower and its Subsidiaries manages and operates its business in accordance with all applicable Legal Requirements except where the failure to so manage or operate could not reasonably be expected to result in a Material Adverse Change; provided that this Section 4.14 does not apply with respect to Environmental Permits.

  • Licenses, etc any license, authorisation, consent or approval at any time necessary to enable any Security Party to comply with its obligations under the Security Documents or the Underlying Documents is revoked or withheld or modified or is otherwise not granted or fails to remain in full force and effect or if any exchange control or other law or regulation shall exist which would make any transaction under the Security Documents or the Underlying Documents or the continuation thereof, unlawful or would prevent the performance by any Security Party of any term of any of the Security Documents or the Underlying Documents; or

  • Material Licenses All Material Licenses have been obtained or exist for each Covered Person.

  • Intellectual Property; Licenses, Etc The Borrower and its Subsidiaries own, or possess the right to use, all of the trademarks, service marks, trade names, copyrights, patents, patent rights, franchises, licenses and other intellectual property rights (collectively, “IP Rights”) that are reasonably necessary for the operation of their respective businesses, without conflict with the rights of any other Person. To the best knowledge of the Borrower, no slogan or other advertising device, product, process, method, substance, part or other material now employed, or now contemplated to be employed, by the Borrower or any Subsidiary infringes upon any rights held by any other Person. No claim or litigation regarding any of the foregoing is pending or, to the best knowledge of the Borrower, threatened, which, either individually or in the aggregate, could reasonably be expected to have a Material Adverse Effect.

  • Patents, Trademarks, Copyrights, Licenses, Etc Each Loan Party and each Subsidiary of each Loan Party owns or possesses all the material patents, trademarks, service marks, trade names, copyrights, licenses, registrations, franchises, permits and rights necessary to own and operate its properties and to carry on its business as presently conducted and planned to be conducted by such Loan Party or Subsidiary, without known possible, alleged or actual conflict with the rights of others.

Time is Money Join Law Insider Premium to draft better contracts faster.